BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 11299859)

  • 1. [Clinical value of "zero-hour" biopsy in kidney transplantation].
    Szakály P; Magyarlaki T; Kalmár NK
    Magy Seb; 2001 Feb; 54(1):18-22. PubMed ID: 11299859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive morphological findings in "zero-hour" biopsies of renal allografts.
    Szánya J; Szakály P; Magyarlaki T; Balogh Z; Nagy J; Nagy KK
    Acta Chir Hung; 1997; 36(1-4):346-8. PubMed ID: 9408397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological factors of 1-h biopsy influencing the delayed renal function and outcome in cadaveric renal allografts.
    Oda A; Morozumi K; Uchida K
    Clin Transplant; 1999; 13 Suppl 1():6-12. PubMed ID: 10751050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathologic evaluation of pretransplant biopsy as a factor influencing graft function after kidney transplantation: a 1-year observation.
    Sulikowski T; Tejchman K; Domański L; Urasińska E; Kamiński M; Zietek Z; Sieńko J; Romanowski M; Safranow K; Bohatyrewicz R; Ciechanowski K; Ostrowski M
    Transplant Proc; 2007 May; 39(4):943-7. PubMed ID: 17524858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of Banff score of early kidney allograft biopsies for 1-year graft survival.
    Kaminska D; Bernat B; Mazanowska O; Krasnowski R; Polak W; Patrzalek D; Kochman A; Klinger M
    Transplant Proc; 2006; 38(1):59-61. PubMed ID: 16504664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The UNOS renal transplant registry.
    Cecka JM
    Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preemptive kidney transplant from deceased donors: an advantage in relation to reduced waiting list.
    Pérez-Flores I; Sánchez-Fructuoso A; Calvo N; Marques M; Anaya S; Ridao N; Rodríguez A; Barrientos A
    Transplant Proc; 2007 Sep; 39(7):2123-4. PubMed ID: 17889112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Histological study in renal grafts--macrophages population in renal grafts].
    Kurose K; Takada T; Yanagihara T; Hara M; Inaba S; Okada T; Kihara I
    Nihon Jinzo Gakkai Shi; 1993 Feb; 35(2):141-50. PubMed ID: 8315877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of microvascular thrombosis in donor kidney allograft biopsies.
    McCall SJ; Tuttle-Newhall JE; Howell DN; Fields TA
    Transplantation; 2003 Jun; 75(11):1847-52. PubMed ID: 12811244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol biopsies in kidney transplant recipients: histologic findings as prognostic markers for graft function and outcome.
    Masin-Spasovska J; Spasovski G; Dzikova S; Grcevska L; Petrusevska G; Lekovski Lj; Popov Z; Ivanovski N
    Transplant Proc; 2005 Mar; 37(2):705-8. PubMed ID: 15848508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of C4d in renal allograft biopsies in different clinical settings: absence of C4d in grafts from non-heart-beating donors.
    Crespo M; Sole M; Arostegui JL; Mila J; Martorell J; Oppenheimer F
    Transplant Proc; 2005 Nov; 37(9):3688-9. PubMed ID: 16386506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Living donor kidney transplants: a biopsy study 1 year after transplantation, compared with baseline changes and correlation to kidney function at 1 and 3 years.
    Sund S; Reisaeter AV; Fauchald P; Bentdal O; Hall KS; Hovig T
    Nephrol Dial Transplant; 1999 Oct; 14(10):2445-54. PubMed ID: 10528671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of kidney transplantation from high-terminal creatinine donors and the role of time-zero biopsy.
    Lin NC; Yang AH; King KL; Wu TH; Yang WC; Loong CC
    Transplant Proc; 2010 Nov; 42(9):3382-6. PubMed ID: 21094783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early and long-term results using older kidneys from cadaver or living donors.
    Berardinelli L; Beretta C; Raiteri M; Carini M
    Clin Transpl; 2001; ():157-66. PubMed ID: 12211778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of free radicals: mediated injury occurring in the kidney donor.
    Kosieradzki M; Kuczynska J; Piwowarska J; Wegrowicz-Rebandel I; Kwiatkowski A; Lisik W; Michalak G; Danielewicz R; Paczek L; Rowinski WA
    Transplantation; 2003 Apr; 75(8):1221-7. PubMed ID: 12717206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of kidney biopsy to determine donation from prospective kidney donors with asymptomatic urinary abnormalities.
    Choi SR; Sun IO; Hong YA; Kim HG; Park HS; Chung BH; Choi BS; Park CW; Kim YS; Yang CW
    Transplant Proc; 2012 Jan; 44(1):11-3. PubMed ID: 22310565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favorable outcome of renal transplantation in patients with IgA nephropathy.
    Andresdottir MB; Hoitsma AJ; Assmann KJ; Wetzels JF
    Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathologic evaluation of pretransplantation biopsy as a factor influencing graft function after kidney transplantation in 3-year observation.
    Sulikowski T; Tejchman K; Ziętek Z; Urasińska E; Domański L; Sieńko J; Romanowski M; Safranow K; Zukowski M; Ciechanowicz A; Ciechanowski K; Ostrowski M
    Transplant Proc; 2010 Nov; 42(9):3375-81. PubMed ID: 21094782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.